Company Comparison
Juno Therapeutics vs 23andMe
Side-by-side comparison of two portfolio companies — sector, funding stage, investors, valuation, and more.
| Metric | Juno Therapeutics | 23andMe |
|---|---|---|
| Sector | Biotech | Biotech |
| Headquarters | — | South San Francisco, California |
| Founded | 2013 | 2006 |
| Status | Active | Active |
| Last Funding Stage | — | — |
| Total Funding | $300M | — |
| Valuation | — | — |
What They Build
Juno Therapeutics
Juno Therapeutics, Inc. was an American biopharmaceutical company founded in 2013 through a collaboration of the Fred Hutchinson Cancer Research Center, Memorial Sloan-Kettering Cancer Center and pediatrics partner Seattle Children's Research Institute.
23andMe
23andMe Holding Co. is an American personal genomics and biotechnology company based in South San Francisco, California.
Key Investors
Juno Therapeutics
Sector Overlap
Both Juno Therapeutics and 23andMe operate in Biotech.
Browse all Biotech companies →